Developments in pharmacogenetics, pharmacogenomics, and personalized medicine

Area of Science:

• Pharmacogenetics and Pharmacogenomics
• Clinical Pharmacology
• Translational Medicine

Background:

• Western Europe has a long history of active research in pharmacogenetics and pharmacogenomics.
• Despite typically low institutional support, European research groups have made substantial international contributions.
• These advancements have laid the groundwork for further studies and clinical integration of pharmacogenomics.

Purpose of the Study:

• To analyze the current state of pharmacogenetics and pharmacogenomics research in Europe.
• To compare European research developments with those in Spain.
• To summarize key contributions and recent clinical applications of pharmacogenomics knowledge.

Main Methods:

• Review and analysis of existing literature on pharmacogenetics and pharmacogenomics in Europe and Spain.
• Historical summary of significant contributions from 1988 to the present.
• Assessment of recent developments in the clinical application of pharmacogenomics.

Main Results:

• European research in pharmacogenetics and pharmacogenomics has achieved international recognition.
• Spain has a notable record of contributions within the European landscape.
• Progress has been made in translating pharmacogenomics knowledge into clinical practice.

Conclusions:

• European and Spanish research has significantly advanced pharmacogenetics and pharmacogenomics.
• Further efforts are needed to enhance the translation of pharmacogenomics findings into routine clinical practice.
• Recommendations are provided to improve clinical implementation in the European context.